rs149661915
Variant summary
Our verdict is Uncertain significance. The variant received 1 ACMG points: 2P and 1B. PM1BP4
The NM_003384.3(VRK1):c.901A>G(p.Lys301Glu) variant causes a missense change. The variant allele was found at a frequency of 0.000304 in 1,612,586 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. K301K) has been classified as Likely benign.
Frequency
Consequence
NM_003384.3 missense
Scores
Clinical Significance
Conservation
Publications
- pontocerebellar hypoplasia type 1AInheritance: AR Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), G2P, PanelApp Australia, Ambry Genetics, Genomics England PanelApp
- microcephaly-complex motor and sensory axonal neuropathy syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- pontocerebellar hypoplasia type 1Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 1 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000283 AC: 43AN: 152168Hom.: 1 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.000228 AC: 57AN: 250424 AF XY: 0.000222 show subpopulations
GnomAD4 exome AF: 0.000306 AC: 447AN: 1460418Hom.: 1 Cov.: 30 AF XY: 0.000299 AC XY: 217AN XY: 726542 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000283 AC: 43AN: 152168Hom.: 1 Cov.: 32 AF XY: 0.000323 AC XY: 24AN XY: 74342 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Pontocerebellar hypoplasia type 1A Uncertain:3
- -
This sequence change replaces lysine, which is basic and polar, with glutamic acid, which is acidic and polar, at codon 301 of the VRK1 protein (p.Lys301Glu). This variant is present in population databases (rs149661915, gnomAD 0.04%). This variant has not been reported in the literature in individuals affected with VRK1-related conditions. ClinVar contains an entry for this variant (Variation ID: 315123). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -
not provided Uncertain:2
Missense variants in this gene are a common cause of disease and they are underrepresented in the general population; In silico analysis indicates that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -
BP4, PM2 -
Congenital pontocerebellar hypoplasia type 1 Uncertain:1
- -
Inborn genetic diseases Uncertain:1
The c.901A>G (p.K301E) alteration is located in exon 11 (coding exon 10) of the VRK1 gene. This alteration results from a A to G substitution at nucleotide position 901, causing the lysine (K) at amino acid position 301 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at